Top 10 Healthcare Devices and Supplies Capital Raises and Investors in the U.S. – April 1st – May 31st, 2026
Several interesting transactions closed in the Healthcare Devices and Supplies sector over the past months. If you would like more info or would like to discuss the capital raising market for your company, please contact me.
PE Growth/Expansion
- Regenity Biosciences, collagen and mineral-based medical devices that support the body’s natural ability to regenerate in areas such as tissue, bone, and nerve repair, received development capital from Cinven.
Merger/Acquisition
- Amplitude Vascular Systems, early-stage medical device that focuses on treating severely calcified arterial disease, was acquired by Stryker for $850 million.
- Noctrix Health, wearable therapeutic devices that treat the symptoms of restless leg syndrome, was acquired by ResMed for $340 million.
Later Stage VC
- BlueWind Medical, medical devices that provide peripheral neuromodulation therapy for urge urinary incontinence, raised $47.8 million of venture funding through a combination of equity and debt.
- Endovascular Engineering, minimally invasive thrombectomy system that removes pulmonary embolisms efficiently while minimizing patient risk, raised $80 million through a combination of Series C-1 and Series C-2 venture funding in a deal led by Gilde Healthcare and Norwest, putting the company’s pre-money valuation at $135 million.
Early Stage VC
- Axena Health, connected medical device that improves outcomes for women with pelvic floor disorders, raised $15.05 million through a combination of Series B, and Series B-1 venture funding from investors, putting the company’s pre-money valuation at $54.95 million.
- CranioSense, medical devices that unlock the hidden parameters of brain health by enabling on-demand neurological insight, raised $510,000 of venture funding from Heinz Ventures, Innovation Works and She’s Independent.
Seed Round
- Focused Cryo, cryoneurolysis system that provides industry-leading spatiotemporal control for nerve cryoneurolysis, raised $8.87 million through a combination of Debt, Seed-1, Seed-2 and Seed-3 funding from GRA Venture Fund and other investors, putting the company’s pre-money valuation at $44.03 million.
- Wavelet Medical, monitoring devices that assess fetal brain development, raised $7 million of seed funding from Aegis Ventures and other investors, putting the company’s pre-money valuation at $12.00 million.
#castleplacement #capitalraising #privateequity #venturecapital #investment #healthcare #medtech #medicaltechnology #healthcaredevices #healthcaresupplies
Tamara Williams
Managing Director
Please contact me if you have any questions or would like to discuss your capital raise:
Email: twilliams@castleplacement.com
(C) (385) 600-1871
Send us a message:
Sources: Information on this page was derived from a variety of sources including Bloomberg, Company Websites, Crunchbase, PitchBook and other news outlets. Castle Placement® does not warrant or guarantee this information, nor makes any representations as to the accuracy of the information. For more Risks, see CPGO Risks and Disclaimers.
